Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGSWW) Gross Margin (2020 - 2025)

GeneDx Holdings has reported Gross Margin over the past 6 years, most recently at 69.65% for Q4 2025.

  • Quarterly results put Gross Margin at 69.65% for Q4 2025, up 43.0% from a year ago — trailing twelve months through Dec 2025 was 69.74% (up 610.0% YoY), and the annual figure for FY2025 was 69.74%, up 610.0%.
  • Gross Margin for Q4 2025 was 69.65% at GeneDx Holdings, down from 72.4% in the prior quarter.
  • Over the last five years, Gross Margin for WGSWW hit a ceiling of 72.4% in Q3 2025 and a floor of 81.83% in Q2 2022.
  • Median Gross Margin over the past 5 years was 42.95% (2023), compared with a mean of 29.51%.
  • Biggest five-year swings in Gross Margin: tumbled -7936bps in 2022 and later skyrocketed 12034bps in 2023.
  • GeneDx Holdings' Gross Margin stood at 4.85% in 2021, then plummeted by -448bps to 26.61% in 2022, then surged by 301bps to 53.56% in 2023, then grew by 29bps to 69.22% in 2024, then grew by 1bps to 69.65% in 2025.
  • The last three reported values for Gross Margin were 69.65% (Q4 2025), 72.4% (Q3 2025), and 69.04% (Q2 2025) per Business Quant data.